Credit: Getty Images. Researchers conducted a retrospective cohort study to assess the impact of an implantable pump on opioid consumption in patients with chronic noncancer pain. Use of an ...

Intrathecal drug delivery involves administering analgesic medications directly into the cerebrospinal fluid, thereby achieving targeted pain relief while minimising systemic side effects. This method ...

A study presented at the American Academy of Pain Medicine’s 26th annual meeting investigated methods for reducing the estimated $1 billion spent annually on pain care treatment in the United States ...

Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree: series of 106 consecutive patients No significant financial relationships to ...

The global intrathecal drug delivery system market is expected to witness significant growth by 2026, due to the increasing prevalence of cancer worldwide. Regionally, the North America region is ...

Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers Actionable Insights in a Secure Cloud Environment DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) ...

Abstract PURPOSE: Implantable intrathecal drug delivery systems (IDDSs) have been used to manage refractory cancer pain, but there are no randomized clinical trial (RCT) data comparing them with ...

PRIALT ® (ziconotide) is the only FDA-approved, non-opioid intrathecal infusion treatment option for patients suffering from severe chronic pain for whom intrathecal therapy is warranted, and who are ...

Dr. Odell received a Bachelor of Science degree in biomedical engineering at Utah State University and went on to receive his medical degree from the Medical College of Wisconsin. He completed ...